欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/0299/001
药品名称Spiriva 18 microgram
活性成分
    • tiotropium bromide monohydrate 22.5 µg
剂型Inhalation powder, hard capsule
上市许可持有人Boehringer Ingelheim International GmbH Bingerstrasse 173 D-55216 Ingelheim am Rhein Germany
参考成员国 - 产品名称Netherlands (NL)
Spiriva 18 microgram, inhalatiepoeder in harde capsules
互认成员国 - 产品名称
    • Liechtenstein (LI)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Spiriva 18µg
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Lithuania (LT)
      Spiriva 18 mikrogramų įkvepiamieji milteliai (kietosios kapsulės)
    • Hungary (HU)
      SPIRIVA 18 mikrogramm inhalációs por kemény kapszulában
    • Bulgaria (BG)
      Spiriva
    • Cyprus (CY)
      SPIRIVA INHALATION PWD HARD CAPS
    • Czechia (CZ)
      Spiriva
    • Romania (RO)
      Spiriva 18 micrograme capsule cu pulbere de inhalat
    • Slovakia (SK)
      Spiriva
    • Slovenia (SI)
    • Malta (MT)
      Spiriva 18 microgram, inhalation powder, hard capsule
许可日期2002/04/02
最近更新日期2024/02/09
药物ATC编码
    • R03BB Anticholinergics
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase